Alan McLachlan

Title: Alan McLachlan: Innovator in Hepatitis B Research

Introduction

Alan McLachlan is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of immunology, particularly in hepatitis B research. With a total of 3 patents, his work has advanced the understanding of T cell epitopes and their role in enhancing immunogenicity.

Latest Patents

Among his latest patents, McLachlan has developed polypeptides that correspond to T cell stimulating regions of the hepatitis B virus (HBV) nucleocapsid protein. These innovations include a method for enhancing the immunogenicity of a polypeptide immunogen by operatively linking the polypeptide through an amino acid residue side chain to core protein particles. This work is crucial for developing effective vaccines and therapies against hepatitis B.

Career Highlights

Throughout his career, McLachlan has worked with esteemed institutions such as the Scripps Clinic and Research Foundation and The Scripps Research Institute. His research has not only contributed to scientific knowledge but has also paved the way for potential clinical applications in immunotherapy.

Collaborations

Some of his notable coworkers include George B. Thornton and Ann M. Moriarty, who have collaborated with him on various research projects, further enhancing the impact of his work in the scientific community.

Conclusion

Alan McLachlan's innovative research in hepatitis B has made a significant impact on the field of immunology. His patents and collaborations reflect his dedication to advancing medical science and improving public health.